Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Artia Global Partners LP (CIK 1937964) reported $499.4M across 47 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: INSM ($148.5M, 29.74%), ABVX ($66.9M, 13.39%), LLY ($35.2M, 7.04%), TRVI ($24.0M, 4.81%), ARGX ($21.7M, 4.35%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | INSM | INSMED INC | $148.5M | 29.74% | 908,412 | Trimmed |
| 2 | ABVX | ABIVAX SA | $66.9M | 13.39% | 600,747 | Trimmed |
| 3 | LLY | ELI LILLY & CO | $35.2M | 7.04% | 38,220 | Trimmed |
| 4 | TRVI | TREVI THERAPEUTICS INC | $24.0M | 4.81% | 2.0M | Hold |
| 5 | ARGX | ARGENX SE | $21.7M | 4.35% | 29,739 | Trimmed |
| 6 | AZNCF | ASTRAZENECA PLC | $18.8M | 3.77% | 95,376 | New |
| 7 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $16.1M | 3.23% | 503,936 | Hold |
| 8 | DNTH | DIANTHUS THERAPEUTICS INC | $13.7M | 2.74% | 162,990 | Trimmed |
| 9 | RVMD | REVOLUTION MEDICINES INC | $12.2M | 2.43% | 124,990 | Added |
| 10 | IONS | IONIS PHARMACEUTICALS INC | $10.8M | 2.17% | 144,376 | Hold |
| 11 | MRNA | MODERNA INC | $10.2M | 2.03% | 200,000 | New |
| 12 | EYPT | EYEPOINT INC | $9.9M | 1.98% | 767,098 | Hold |
| 13 | DGX | QUEST DIAGNOSTICS INC | $8.0M | 1.60% | 40,817 | Hold |
| 14 | ALMS | ALUMIS INC | $7.2M | 1.43% | 325,046 | New |
| 15 | VKTX | VIKING THERAPEUTICS INC | $5.9M | 1.18% | 180,731 | Trimmed |
| 16 | MRK | MERCK & CO INC | $5.6M | 1.12% | 46,700 | New |
| 17 | TERN | TERNS PHARMACEUTICALS INC | $5.5M | 1.11% | 104,800 | New |
| 18 | JNJ | JOHNSON & JOHNSON | $5.5M | 1.11% | 22,600 | New |
| 19 | SION | SIONNA THERAPEUTICS INC | $4.8M | 0.96% | 119,741 | Hold |
| 20 | SRRK | SCHOLAR ROCK HLDG CORP | $4.7M | 0.95% | 96,285 | Hold |
| 21 | RAPP | RAPPORT THERAPEUTICS INC | $4.3M | 0.87% | 138,508 | Hold |
| 22 | ASND | ASCENDIS PHARMA A/S | $4.1M | 0.81% | 17,740 | Hold |
| 23 | BLTE | BELITE BIO INC | $4.0M | 0.80% | 24,989 | Added |
| 24 | XENE | XENON PHARMACEUTICALS INC | $3.8M | 0.76% | 65,000 | Added |
| 25 | MLYS | MINERALYS THERAPEUTICS INC | $3.7M | 0.75% | 137,800 | Hold |
Source: SEC Form 13F filings · as of 2026-03-31